SIME Clinical AI Platform could enable early targeted treatment in critically ill COVID-19 patients

A recent peer reviewed letter to editor by SIME has been published in Critical Care [...]

Investing in our future starts with prioritising infant healthcare

A recent study published in The Lancet suggests that falling fertility rates across nearly every [...]

AI Predicts Newborn Chronic Lung Disease in Breakthrough Clinical Study

Innovative screening test has the potential to enable early preventative care for millions of babies [...]

SIME Announces Exclusive Agreement for Commercialisation of Respiratory Diagnostic Platform in Latin America

Partnership will accelerate path to commercialisation of novel respiratory diagnostics LONDON, May 7, 2020 /PRNewswire/ — Today, [...]

Press Release: ‘SIME Completes Study Validating Clinical AI Platform in Neonatal Respiratory Care’

Data demonstrating that AI accurately predicts Respiratory Distress Syndrome (RDS) in premature babies, enables company [...]

HOW CLINICAL AI IS GENERATING UNIQUE DATA FROM YOUR BIOLOGY

Published online on Medium, 17th April 2019 Over a decade ago, the human genome was [...]

WORLD PREMATURITY DAY INFOGRAPHIC

World Prematurity Day is observed on 17 November each year to raise awareness of preterm [...]

PRESS RELEASE: SIME AWARDED PATENT FOR NEONATAL POINT-OF-CARE LUNG MATURITY TEST (LMT)

SIME Dx today announced that the European Patent Office intends to grant patent number 14727196.9 [...]

MICROSOFT FEATURE: HOW MACHINE LEARNING WILL TRANSFORM CARE FOR MILLIONS OF PREMATURE BABIES IN CHINA

At SIME Diagnostics we are developing a digital platform that can measure multiple biomarkers, from [...]

PRESS RELEASE: SIME DX ANNOUNCES NEW DESIGN FOR LUNG MATURITY DIAGNOSTIC DEVICE

LONDON, August 15, 2018 /PRNewswire/ — Device fully automates neonatal Lung Maturity Test (LMT),representing a major milestone achievement andputtingLMT on track for final clinical validation and [...]